Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Clin Cancer Res. 2024 May 1;30(9):1822–1832. doi: 10.1158/1078-0432.CCR-23-3709

Figure 2: Associations between hs-CRP and Homocysteine and neurocognitive outcomes among survivors of Hodgkin lymphoma.

Figure 2:

The figures below represent the mean difference and 95% confidence interval (CI) in neurocognitive z-score comparing the second tertile (circles) and the third tertile (squares) to the first tertile (1.0 ref.) for A) c-reactive protein (CRP) and B) homocysteine. Models are adjusted for age at evaluation, sex, race, body mass index, current anti-inflammatory use, and recent infection.